2005
DOI: 10.1186/1471-2407-5-152
|View full text |Cite
|
Sign up to set email alerts
|

Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer

Abstract: BackgroundHypoxia compromises local control in patients with head-and-neck cancer (HNC). In order to determine the value of [18F]-fluoromisonidazole (Fmiso) with regard to tumor hypoxia, a patient study with dynamic Fmiso PET was performed. For a better understanding of tracer uptake and distribution, a kinetic model was developed to analyze dynamic Fmiso PET data.MethodsFor 15 HNC patients, dynamic Fmiso PET examinations were performed prior to radiotherapy (RT) treatment. The data was analyzed using a two co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
110
0
7

Year Published

2006
2006
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 159 publications
(123 citation statements)
references
References 28 publications
6
110
0
7
Order By: Relevance
“…28 On the other hand, hypoxia (decreased blood flow) enhances chemoresistance and impedes delivery of therapeutic agents. 29 However, the relationship between HNSCC perfusion and hypoxia may be complex as recently described by several investigators 30,31 who used dynamic [ 18 F]luoromisonidazole PET to assess the perfusion of the primary tumor while simultaneously assessing tumor hypoxia through misonidazole binding. These investigators demonstrated that HNSCC tumors might have significant heterogeneous regions characterized by various perfusion-oxygenation relationships.…”
Section: Discussionmentioning
confidence: 99%
“…28 On the other hand, hypoxia (decreased blood flow) enhances chemoresistance and impedes delivery of therapeutic agents. 29 However, the relationship between HNSCC perfusion and hypoxia may be complex as recently described by several investigators 30,31 who used dynamic [ 18 F]luoromisonidazole PET to assess the perfusion of the primary tumor while simultaneously assessing tumor hypoxia through misonidazole binding. These investigators demonstrated that HNSCC tumors might have significant heterogeneous regions characterized by various perfusion-oxygenation relationships.…”
Section: Discussionmentioning
confidence: 99%
“…First, the treatment plans were done using on a single 18 F-FMISO PET scan performed at āˆ¼2.5 h after injection. Studies by others (72,73) have shown potential limitations with single time point imaging and have proposed a dynamic scanning approach. In the latter method, the kinetic information of the tracer uptake and retention behavior in each PET image voxel is used to generate parametric maps of putative hypoxia tracer trapping using compartmental models of the tracer binding chemistry (71,72).…”
Section: Discussionmentioning
confidence: 99%
“…Koh et al [221] , Liu et al [222] , Yeh et al [223] , Rischin et al [224] , Bentzen et al [125] , Rajendran et al [225] , Gagel et al [126] , Rajendran et al [226] , Hicks et al [227] , Lawrentschuk et al [200] , Loi et al [228] , Thorwarth et al [229] , Rajendran et al [230] , Rischin et al [231] , Thorwarth et al [232] , Zimny et al [124] , Eschmann et al [233] , Gagel et al [202] , Thorwarth et al [234] , Thorwarth et al [235] , Lee et al [236] , Lin et al [237] , Nehmeh et al [238] , Roels et al [239] , Dirix et al [240] , Lee et al [241] , Mortensen et al [127] , Wang et al [56] , Abolmaali et al [242] , Bowen et al [138] , Eary et al [243] , Kikuchi et al [244] , Hugonnet et al [131] , Yamane et al [245] , Mammar et al [246] , Zips et al [247] , Cheng et al [217] , Henriques de Figueiredo et al [248] , Okamoto et al [249] , Sato et al [218] , Segard et al [250] , Tachibana et al [251] , Norikane et al [219] [ Dubois et al …”
Section: F]fmisomentioning
confidence: 99%